Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Neurology|February 4, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)Daniel Engels, Mariella Herfurth, Joachim Havla, et al.
BMJ Neurology Open|October 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)Anna Walz, Daria Tkachenko, Martin W Hümmert, et al.
Neurological Research and Practice|May 5, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disordersDaria Tkachenko, Ilya Ayzenberg, Louisa M Schöppe, et al.
Neurology|December 16, 2022
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter StudySara Carta, Álvaro Cobo Calvo, Thaís Armangué, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2023
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)Martin W Hümmert, Carlotta Stern, Friedemann Paul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)Sarah Passoke, Carlotta Stern, Vivien Häußler, et al.
Brain : a Journal of Neurology|July 18, 2024
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulationTilman Schneider-Hohendorf, Christian Wünsch, Simon Falk, et al.
Neurology|July 2, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort StudyDaniel Engels, Patrick Schindler, Joachim Havla, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2024
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacksCarolin Schwake, Theodoros Ladopoulos, Vivien Häußler, et al.
JAMA Neurology|August 7, 2023
Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System DemyelinationAna Beatriz Ayroza Galvão Ribeiro Gomes, Laila Kulsvehagen, Patrick Lipps, et al.
Pageof 3